Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Povidone Iodine for Intraoperative SARS-CoV-2 Prevention
NCT05745467Phase 4Withdrawn
- Sponsor
- University of Iowa
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of povidone-iodine in coronavirus disease 2019 (COVID-19), sponsored by University of Iowa. Planned start Jul 2024; status: withdrawn.
02
Drugs
povidone-iodine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05745467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05745467.